Azoy Alexander 4
4 · Arcus Biosciences, Inc. · Filed Jan 27, 2025
Insider Transaction Report
Form 4
Azoy Alexander
Chief Accounting Officer
Transactions
- Award
Common Stock
2025-01-23+17,100→ 30,194 total - Award
Stock Option (right to buy)
2025-01-23+11,400→ 11,400 totalExercise: $13.33Exp: 2035-01-22→ Common Stock (11,400 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2025, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company.